Miscellaneous Health Regulations Amendments

Summary#

These are final, miscellaneous amendments published as SOR/2026-113 that make small wording, language, and reference fixes across a number of Health-related regulations. They remove a few obsolete provisions, correct English–French inconsistencies, update references to technical standards, and clarify some labelling and record-keeping points. The amendments took effect on June 4, 2026 (the day they were registered) and were published in the Canada Gazette on June 17, 2026.

What it does#

• Fixes wording and translation mismatches between English and French to reduce confusion and inconsistent interpretation.
• Repeals obsolete or spent provisions that no longer apply, for example in the Cannabis Regulations and parts of the Food and Drug Regulations.
• Updates references to modern technical standards, for example:
  • the mattress test standard updated to CAN/CGSB-4.2 No. 27.7-2023,
  • a U.S. Code reference for lighters updated to the edition as of January 1, 2025,
  • certain ASTM and CAN/ULC standard dates corrected.
• Clarifies labelling and safety wording in the Food and Drug Regulations, including clearer requirements for:
  • children’s dosing (maximums by age: 10–14 years = one-half adult dose; 5–9 = one-fourth; 2–4 = one-sixth; under 2 = as directed by a physician),
  • a warning statement for certain coated potassium tablets,
  • which information must be counted when deciding if a nutrition table fits on a package.
• Clarifies record-keeping for drug fabricators and packagers (what written specifications, test evidence and test results must be kept on premises).
• Makes small technical edits in a number of other regulations to modernize wording or align terms (examples include the Biocides Regulations, Human Pathogens and Toxins Regulations, Safety of Sperm and Ova Regulations, Industrial Hemp Regulations, Residential Detectors Regulations, Consumer Chemicals and Containers Regulations, 2001, Glazed Ceramics and Glassware Regulations, and the Lighters Regulations).

Who's affected#

• Manufacturers and packagers of drugs, foods, consumer products, mattresses, lighters, detectors, and glazed ceramics and glassware.
• Licensed cannabis producers and industrial hemp growers (only where transitional provisions had already expired).
• Clinical sperm/ova facilities and organizations that handle human reproductive material.
• Laboratories and facilities that work with human pathogens and toxins.
• Regulators and compliance staff at Health Canada and the Public Health Agency of Canada (PHAC).
• The government’s summary says these are non‑substantive changes and that the amendments do not increase costs for businesses; the small business lens found no expected impact on small businesses.

Why it matters#

• These changes are mostly technical. They reduce the risk of inconsistent interpretation between English and French rules.
• Updating standard references and clarifying wording makes it easier for companies and inspectors to know which tests or labels are required today.
• Repealing outdated rules removes confusion about requirements that no longer apply.
• Because the amendments are described as non‑substantive, they are not intended to change safety rules or add new costs. They simply tidy up the regulations so enforcement and compliance are clearer.